Saliogen Therapeutics
Developer of genome engineering platform designed to provide durable, safe, and affordable non-viral gene therapy to pat
Drug Discovery
📍 Foxboro, MA
Founded 2020
Current Valuation
$632M
as of 2022-Q2
PRIVATE
Developer of genome engineering platform designed to provide durable, safe, and affordable non-viral gene therapy to patients with inherited diseases.
Company Profile
Last Round
Series B — $132M (Apr 2022)
Fundraising Status
Series B · $132M · 4y 2mo ago
privateTotal raised $152M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $132M | Apr 2022 | — | $632M |
BiotechnologyGeneticsLife ScienceTherapeutics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q2. Refreshed quarterly.